SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)
UCI MEDICAL AFFILIATES, INC.
(Name of Issuer)
Common Stock, Par Value $0.05 Per Share
(Title of Class of Securities)
902633 10 6
(CUSIP Number)
This amendment to Schedule 13G is being filed pursuant to Rule 101(a)(2)(ii) of
Regulation S-T.
(Continued on following pages.)
<PAGE>
CUSIP No.: 902633 10 6 13G
---------------
1. NAMES OF REPORTING PERSONS
IRS IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Marion Fletcher McFarland, III
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / / (b) / /
--- ---
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
5. SOLE VOTING POWER 589,128
Number of Shares
6. SHARED VOTING POWER 0
Beneficially Owned By
7. SOLE DISPOSITIVE POWER 589,128
Each Reporting Person With:
8. SHARED DISPOSITIVE POWER 0
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 589,128
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
/ /
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.65 %
12. TYPE OF REPORTING PERSON
IN
<PAGE>
The statement on Schedule 13G ( the "Statement") filed on February 14,
1986 by Marion Fletcher McFarland, III with respect to the common stock, par
value $0.05 per share (the "Common Stock"), of UCI Medical Affiliates, Inc. as
amended, is hereby further amended by amendments to Item 4, Ownership. Items 1-3
and 5-10 are restated herein in compliance with Rule 101(a)(2)(ii) of Regulation
S-T, but are not amended hereby.
Item 1(a). Name of Issuer:
UCI Medical Affiliates, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
1901 Main Street, Suite 1200, Mail Code 1105,
Columbia, SC 29201
Item 2(a). Name of Person Filing:
Marion Fletcher McFarland, III
Item 2(b). Address of Principal Business Office, or, if None, Residence:
1901 Main Street, Suite 1200, Mail Code 1105,
Columbia, SC 29201
Item 2(c). Citizenship:
United States of America
Item 2(d). Title of Class of Securities:
Common Stock, Par Value $0.05 Per Share
Item 2(e). CUSIP Number:
902633 10 6
Item 3. This statement on Schedule 13G is filed pursuant to Rule
13d-1(c) and not pursuant to Rule 13d-1(b) or Rule 13d-2(b).
Item 4. Ownership.
Items 4(a), (b), and (c) of the Statement are hereby amended
by deleting the language contained under Items 4(a), (b), and
(c) of the Statement and substituting in their place the
following:
"(a) Amount Beneficially Owned:
Marion F. McFarland, III, M.D. has direct beneficial ownership
of 589,128 shares of Common Stock. This amount includes 50,000
shares of Common Stock that Dr. McFarland has the right to
acquire pursuant to currently exercisable options and options
exercisable within 60 days following December 31, 1997,
granted by the Company to Dr. McFarland. This amount does not
include 156,675 shares of Common Stock that Dr. McFarland has
the right to acquire pursuant to options that are not
currently exercisable or exercisable within 60 days following
December 31, 1997.
(b) Percent of Class: 9.65 %
(c) Number of shares of Common Stock as to which Marion
Fletcher McFarland has:
(i) sole power to vote or to direct the vote: 589,128
(ii) shared power to vote or to direct the vote: -0-
(iii) sole power to dispose or to direct the disposition
of: 589,128
(iv) shared power to dispose or to direct the disposition
of: -0-"
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following / /.
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent
Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
Not applicable.
<PAGE>
13G
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete, and
correct.
Marion Fletcher McFarland, III, M.D.
Date: February 17, 1998
